No Data
No Data
Oldies Are Goldies: Buy These 5 Surging Old Economy Stocks
Crane (NYSE:CR) Has A Pretty Healthy Balance Sheet
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' When we think about how risky a company is, we always like
J&J's Talvey Demonstrates Robust Long-term Response in Multiple Myeloma
CR Double-Crane Pharmaceutical Gets Certificate to Market Low-Calcium Dialysis Solution
China Resources Double-Crane Pharmaceutical (SHA:600062) obtained a drug registration certificate from drug regulator National Medical Products Administration for its low-calcium peritoneal dialysis s
Is Now The Time To Look At Buying Crane Company (NYSE:CR)?
The Zacks Analyst Blog Highlights Applied Industrial Technologies, Crane, Ingersoll Rand and Flowserve
No Data